EA201101297A1 - Аддитивные соли аминов, содержащих гидроксильные и/или карбоксильные группы, с производными аминоникотиновой кислоты в качестве ингибиторов dhodh - Google Patents
Аддитивные соли аминов, содержащих гидроксильные и/или карбоксильные группы, с производными аминоникотиновой кислоты в качестве ингибиторов dhodhInfo
- Publication number
- EA201101297A1 EA201101297A1 EA201101297A EA201101297A EA201101297A1 EA 201101297 A1 EA201101297 A1 EA 201101297A1 EA 201101297 A EA201101297 A EA 201101297A EA 201101297 A EA201101297 A EA 201101297A EA 201101297 A1 EA201101297 A1 EA 201101297A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- groups
- acid derivatives
- carboxyl groups
- aminonicotinic acid
- additive salts
- Prior art date
Links
- KPIVDNYJNOPGBE-UHFFFAOYSA-N 2-aminonicotinic acid Chemical class NC1=NC=CC=C1C(O)=O KPIVDNYJNOPGBE-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000654 additive Substances 0.000 title abstract 2
- 230000000996 additive effect Effects 0.000 title abstract 2
- 150000001412 amines Chemical class 0.000 title abstract 2
- -1 CARBOXYL GROUPS Chemical group 0.000 title 1
- 108010052167 Dihydroorotate Dehydrogenase Proteins 0.000 title 1
- 102100032823 Dihydroorotate dehydrogenase (quinone), mitochondrial Human genes 0.000 title 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical class [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Настоящее изобретение относится к новым водорастворимым фармацевтически приемлемым кристаллическим аддитивным солям (i) амина, содержащего одну или несколько гидроксильных и/или карбоксильных групп, с (ii) производными аминоникотиновой кислоты формулы (I), где R, R, Rи Rнезависимо представляют собой группы, выбранные из атомов водорода, атомов галогена, Салкильных групп, которые необязательно могут быть замещены 1, 2 или 3 заместителями, выбранными из атомов галогена и гидроксигрупп, и Салкоксигрупп, которые необязательно могут быть замещены 1, 2 или 3 заместителями, выбранными из атомов галогена и гидроксигрупп, и их фармацевтически приемлемым сольватам.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09382031A EP2228367A1 (en) | 2009-03-13 | 2009-03-13 | Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as DHODH inhibitors |
| PCT/EP2010/001550 WO2010102826A1 (en) | 2009-03-13 | 2010-03-11 | Addition salts of amines containing hydroxyl and/or carboxylic groups with amino nicotinic acid derivatives as dhodh inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201101297A1 true EA201101297A1 (ru) | 2012-04-30 |
| EA022350B1 EA022350B1 (ru) | 2015-12-30 |
Family
ID=40677683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201101297A EA022350B1 (ru) | 2009-03-13 | 2010-03-11 | Аддитивные соли аминов, содержащих гидроксильные и/или карбоксильные группы, с производными аминоникотиновой кислоты в качестве ингибиторов dhodh |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US20120014918A1 (ru) |
| EP (2) | EP2228367A1 (ru) |
| JP (1) | JP5674685B2 (ru) |
| KR (1) | KR101674699B1 (ru) |
| CN (1) | CN102348689B (ru) |
| AR (1) | AR075738A1 (ru) |
| AU (1) | AU2010223528B2 (ru) |
| BR (1) | BRPI1006766B8 (ru) |
| CA (1) | CA2754804C (ru) |
| CL (1) | CL2011002216A1 (ru) |
| CO (1) | CO6420337A2 (ru) |
| CY (1) | CY1114418T1 (ru) |
| DK (1) | DK2406225T3 (ru) |
| EA (1) | EA022350B1 (ru) |
| EC (1) | ECSP11011365A (ru) |
| ES (1) | ES2428746T3 (ru) |
| HR (1) | HRP20130851T1 (ru) |
| IL (1) | IL214519A (ru) |
| ME (1) | ME01564B (ru) |
| MX (1) | MX2011009146A (ru) |
| MY (1) | MY155140A (ru) |
| NZ (1) | NZ594493A (ru) |
| PE (1) | PE20120171A1 (ru) |
| PL (1) | PL2406225T3 (ru) |
| PT (1) | PT2406225E (ru) |
| RS (1) | RS52949B (ru) |
| SG (1) | SG173823A1 (ru) |
| SI (1) | SI2406225T1 (ru) |
| SM (1) | SMT201300104B (ru) |
| TW (1) | TWI428127B (ru) |
| UA (1) | UA105786C2 (ru) |
| UY (1) | UY32467A (ru) |
| WO (1) | WO2010102826A1 (ru) |
| ZA (1) | ZA201105744B (ru) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2319596B1 (es) | 2006-12-22 | 2010-02-08 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
| UY31272A1 (es) | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
| EP2135610A1 (en) | 2008-06-20 | 2009-12-23 | Laboratorios Almirall, S.A. | Combination comprising DHODH inhibitors and methotrexate |
| EP2239256A1 (en) | 2009-03-13 | 2010-10-13 | Almirall, S.A. | Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor |
| EP2314577A1 (en) | 2009-10-16 | 2011-04-27 | Almirall, S.A. | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid |
| EP2444088A1 (en) * | 2010-10-22 | 2012-04-25 | Almirall, S.A. | Amino derivatives for the treatment of proliferative skin disorders |
| EP2594271A1 (en) * | 2011-11-21 | 2013-05-22 | Almirall, S.A. | 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid for the treatment of psoriasis. |
| KR101251851B1 (ko) | 2011-11-30 | 2013-04-10 | 현대자동차주식회사 | Ｉｓｇ 시스템 및 이의 제어방법 |
| TW201350467A (zh) * | 2012-05-08 | 2013-12-16 | Teva Pharma | Ｎ－乙基－４－羥基－１－甲基－５－（甲基（２，３，４，５，６－五羥基己基）胺基）－２－側氧－ｎ－苯基－１，２－二氫喹啉－３－甲醯胺 |
| TW201400117A (zh) * | 2012-06-05 | 2014-01-01 | Teva Pharma | 使用拉喹莫德治療眼發炎疾病 |
| US20160051679A1 (en) * | 2013-04-12 | 2016-02-25 | Actavis Group Ptc Ehf. | Pemetrexed Formulation |
| WO2018136009A1 (en) | 2017-01-20 | 2018-07-26 | Aslan Pharmaceuticals Pte Ltd | Combination therapy |
| WO2018136010A1 (en) | 2017-01-20 | 2018-07-26 | Aslan Pharmaceuticals Pte Ltd | Combination therapy |
| CN108530310B (zh) * | 2017-03-02 | 2025-01-28 | 中国科学院上海药物研究所 | 2-(取代苯杂基)芳香甲酸类fto抑制剂，其制备方法及其应用 |
| CN110662539B (zh) | 2017-04-24 | 2023-08-15 | 奥里吉恩探索技术有限公司 | 三取代的苯并三唑衍生物作为二氢乳清酸加氧酶抑制剂的使用方法 |
| KR20200123137A (ko) | 2018-02-20 | 2020-10-28 | 아지오스 파마슈티컬스 아이엔씨. | 삼치환 벤조트리아졸 유도체의 사용 방법 |
| CN112969699A (zh) | 2018-10-09 | 2021-06-15 | 亚狮康私人有限公司 | 瓦利替尼的丙二酸盐 |
| SG11202106526UA (en) * | 2018-12-21 | 2021-07-29 | Les Laboratoires Servier Sas | Crystalline and salt forms of an organic compound and pharmaceutical compositions thereof |
| KR20230116779A (ko) * | 2020-10-15 | 2023-08-04 | 아슬란 파마슈티컬스 피티이 엘티디 | 디히드로오로테이트 헤하이드로즈네이즈(dhodh) 저해제를 이용한 자가면역 질환의 치료 |
| CN114907267A (zh) * | 2021-02-08 | 2022-08-16 | 中国科学院上海药物研究所 | 用于抗肿瘤的药物组合 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3839344A (en) * | 1973-03-28 | 1974-10-01 | Schering Corp | N-methyl d-glucamine salt of 2(2'-methyl-3'-trifluoromethylanilino)nicotinic acid |
| GB9804343D0 (en) | 1998-02-27 | 1998-04-22 | Univ Cardiff | Chemical compounds |
| AU775157B2 (en) * | 1999-06-10 | 2004-07-22 | Warner-Lambert Company Llc | Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| ATE396719T1 (de) | 2001-04-05 | 2008-06-15 | Aventis Pharma Inc | Verwendung von (z)-2-cyano-3-hydroxy-but-2- ensäure-(4'-trifluoromethylphenyl)-amid zur behandlung der multiplen sklerose |
| WO2003006424A1 (en) | 2001-07-10 | 2003-01-23 | 4Sc Ag | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| JP2004099586A (ja) * | 2002-05-21 | 2004-04-02 | Sumitomo Pharmaceut Co Ltd | ジヒドロオロテートデヒドロゲナーゼ阻害剤 |
| AU2003300530A1 (en) | 2002-12-23 | 2004-07-14 | 4Sc Ag | Dhodh-inhibitors and method for their identification |
| WO2004056746A1 (en) | 2002-12-23 | 2004-07-08 | 4Sc Ag | Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| US20070219224A1 (en) | 2004-05-21 | 2007-09-20 | Uab Research Foundation, The | Compositions and Methods Relating to Pyrimidine Synthesis Inhibitors |
| WO2006022442A1 (ja) | 2004-08-24 | 2006-03-02 | Santen Pharmaceutical Co., Ltd. | ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体 |
| AU2005295511A1 (en) | 2004-10-19 | 2006-04-27 | Aventis Pharmaceuticals Inc. | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease |
| JP2007015952A (ja) * | 2005-07-06 | 2007-01-25 | Shionogi & Co Ltd | ナフタレン誘導体 |
| ES2303758B1 (es) | 2006-02-20 | 2009-08-13 | Laboratorios Almirall S.A. | Nuevos derivados de piridin-3-amina. |
| ES2301380B1 (es) | 2006-08-09 | 2009-06-08 | Laboratorios Almirall S.A. | Nuevos derivados de 1,7-naftiridina. |
| ES2319596B1 (es) | 2006-12-22 | 2010-02-08 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
| UY31272A1 (es) * | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
-
2009
- 2009-03-13 EP EP09382031A patent/EP2228367A1/en not_active Withdrawn
-
2010
- 2010-02-24 UY UY0001032467A patent/UY32467A/es active IP Right Grant
- 2010-03-08 TW TW099106617A patent/TWI428127B/zh active
- 2010-03-11 EP EP10708932.8A patent/EP2406225B1/en active Active
- 2010-03-11 US US13/256,349 patent/US20120014918A1/en not_active Abandoned
- 2010-03-11 HR HRP20130851AT patent/HRP20130851T1/hr unknown
- 2010-03-11 NZ NZ594493A patent/NZ594493A/xx unknown
- 2010-03-11 ME MEP-2013-106A patent/ME01564B/me unknown
- 2010-03-11 BR BRPI1006766A patent/BRPI1006766B8/pt active IP Right Grant
- 2010-03-11 SG SG2011060811A patent/SG173823A1/en unknown
- 2010-03-11 WO PCT/EP2010/001550 patent/WO2010102826A1/en active Application Filing
- 2010-03-11 PE PE2011001599A patent/PE20120171A1/es active IP Right Grant
- 2010-03-11 RS RS20130394A patent/RS52949B/en unknown
- 2010-03-11 MY MYPI2011004300A patent/MY155140A/en unknown
- 2010-03-11 KR KR1020117021314A patent/KR101674699B1/ko active Active
- 2010-03-11 AU AU2010223528A patent/AU2010223528B2/en active Active
- 2010-03-11 MX MX2011009146A patent/MX2011009146A/es active IP Right Grant
- 2010-03-11 CN CN201080011530.6A patent/CN102348689B/zh active Active
- 2010-03-11 SI SI201030344T patent/SI2406225T1/sl unknown
- 2010-03-11 AR ARP100100741A patent/AR075738A1/es not_active Application Discontinuation
- 2010-03-11 JP JP2011553360A patent/JP5674685B2/ja active Active
- 2010-03-11 PL PL10708932T patent/PL2406225T3/pl unknown
- 2010-03-11 CA CA2754804A patent/CA2754804C/en active Active
- 2010-03-11 DK DK10708932.8T patent/DK2406225T3/da active
- 2010-03-11 PT PT107089328T patent/PT2406225E/pt unknown
- 2010-03-11 UA UAA201111802A patent/UA105786C2/ru unknown
- 2010-03-11 ES ES10708932T patent/ES2428746T3/es active Active
- 2010-03-11 EA EA201101297A patent/EA022350B1/ru unknown
-
2011
- 2011-08-04 ZA ZA2011/05744A patent/ZA201105744B/en unknown
- 2011-08-08 IL IL214519A patent/IL214519A/en active IP Right Grant
- 2011-09-01 CO CO11112338A patent/CO6420337A2/es not_active Application Discontinuation
- 2011-09-08 CL CL2011002216A patent/CL2011002216A1/es unknown
- 2011-09-30 EC EC2011011365A patent/ECSP11011365A/es unknown
-
2013
- 2013-09-18 CY CY20131100818T patent/CY1114418T1/el unknown
- 2013-09-23 SM SM201300104T patent/SMT201300104B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201101297A1 (ru) | Аддитивные соли аминов, содержащих гидроксильные и/или карбоксильные группы, с производными аминоникотиновой кислоты в качестве ингибиторов dhodh | |
| CR20110013A (es) | Derivados de Heteroarilo como Inhibidores de DGAT1 | |
| EA201591429A1 (ru) | 2,3-дизамещенные производные 1-ацил-4-амино-1,2,3,4-тетрагидрохинолинов и их применение в качестве ингибиторов бромодомена | |
| MX2011013771A (es) | Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17. | |
| MX2013012776A (es) | Inhibidores de la tirosina cinasa de bazo que contienen aminopiridina. | |
| EA201170096A1 (ru) | Замещенные производные пиримидона | |
| PH12013501196B1 (en) | Indeno- fused ring compounds having photochromic properties | |
| AU2011209274A8 (en) | Substituted naphthyridines and their use as Syk kinase inhibitors | |
| PH12013501197B1 (en) | Indeno-fused ring compounds | |
| UA109525C2 (xx) | Алкіламідна сполука і її застосування | |
| TW200833675A (en) | Nicotinamide derivatives | |
| RS54288B1 (en) | SUBSTITUTED TRIAZOLOPYRIDINES AND THEIR USE AS TTK INHIBITORS | |
| UA97821C2 (en) | Cyclized derivatives as eg-5 inhibitors | |
| EA201291217A1 (ru) | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 1-(β-D-ГЛЮКОПИРАНОЗИЛ)-2-ТИЕНИЛМЕТИЛБЕНЗОЛА КАК ИНГИБИТОРЫ НЗПГ | |
| EA201390163A1 (ru) | Гетеробициклические производные в качетстве ингибиторов hcv | |
| MY147188A (en) | Substituted imidazole compounds as ksp inhibitors | |
| MX347476B (es) | Compuestos de ácido dimetil-benzoico. | |
| EA201270816A1 (ru) | Производные бензамида и их применение в качестве ингибиторов hsp90 | |
| MX2013007938A (es) | Compuesto biciclico novedoso o sal del mismo. | |
| DK1753723T3 (da) | Substituerede quinolinderivater som mitotiske kinesininhibitorer | |
| EA201101298A1 (ru) | Аддитивные соли трометамина с производными азабифениламинобензойной кислоты в качестве ингибиторов dhodh | |
| EA201270421A1 (ru) | 1,2-дигидро-2-оксохинолиновые соединения в качестве лигандов рецептора 5-нт | |
| MX359399B (es) | Inhibidores de 17alfa-hidroxilasa/c17-20-liasa. | |
| EA200700360A1 (ru) | Новые производные амида гетероциклической карбоновой кислоты | |
| RS53965B1 (en) | ACILBENZENA DERIVATIVES |